ETON
Eton Pharmaceuticals Inc
55.60$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.9% | 97.1% | 87.9% | 93.9% | 85.9% | 79.9% | 84.6% | 53.9% | 65.8% | |
| 97.9% | 94.4% | 70.7% | 80.9% | 52.5% | 65.1% | 67.4% | 19.6% | 28.2% | |
| 97.9% | 94.4% | 70.7% | 80.9% | 52.5% | 65.1% | 67.4% | 19.6% | 28.2% | |
| – | – | 2.8% | 0.2% | 19.9% | 7.4% | 10.7% | 7.0% | 12.8% | |
| 0.0% | 0.0% | 2.2% | 4.7% | 2.0% | 2.2% | 2.9% | 20.0% | 16.7% | |
| 0.9% | 2.7% | 7.5% | 3.8% | 0.8% | 0.3% | – | – | – | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 4.2% | 2.2% | 13.2% | 19.0% | 14.9% | 45.8% | 33.5% | |
| 9.8% | 7.1% | 38.2% | 40.5% | 35.8% | 47.8% | 51.2% | 67.9% | 71.6% | |
| 5.9% | 7.1% | 11.5% | 14.4% | 16.6% | 25.8% | 51.2% | 26.2% | 41.8% | |
| 0.0% | 0.0% | 0.8% | 1.1% | 5.2% | 4.1% | 17.0% | 0.1% | 9.5% | |
| 4.0% | 5.0% | 3.4% | 8.9% | 6.5% | 7.1% | 5.8% | 5.5% | 11.9% | |
| 0.0% | 0.0% | 26.6% | 25.7% | 19.2% | 21.5% | – | 39.2% | 23.6% | |
| 90.2% | 92.9% | 61.8% | 59.5% | 64.2% | 52.2% | 48.8% | 32.1% | 28.4% | |
| -64.3% | -161.9% | -376.0% | -350.2% | -342.7% | -412.0% | -327.9% | -141.7% | -122.1% | |
| 129.9% | 22.7% | 104.0% | 79.8% | 91.8% | 100.5% | 80.8% | 34.0% | 29.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.